Novartis Drops Patent Claims Against Ranbaxy
Pharmaceutical company Novartis International AG has indicated that it is dropping its patent claims against Ranbaxy Laboratories Limited over the top-selling hypertension drug Diovan....To view the full article, register now.
Already a subscriber? Click here to view full article